NCT04866342View on ClinicalTrials.gov

Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 27, 2020

Primary Completion Date

August 28, 2023

Study Completion Date

August 28, 2023

Conditions
PrematurePremature InfantOxygen TherapyHypoxiaHyperoxiaObstetric Labor, Premature
Interventions
DEVICE

Servo control (closed-loop automatic control of the inspiratory fraction of oxygen (FiO2)) - IntellO2 OAM

"FiO2 adjustments will be made by the IntellO2 Oxygen Assist Module (OAM) for Precision Flow (IntellO2, Vapotherm, USA). By means of a modified closed-loop algorithm, the devise uses MasimoSET or Nellcor pulse oximetry to target a user-set SpO2 value.~Manual adjustments of the inspired oxygen fraction can additionally be made as per standard care."

Trial Locations (1)

EH16 4SA

The Simpson Centre for Reproductive Health, Royal Infirmary Edinburgh, Edinburgh

All Listed Sponsors
collaborator

NHS Lothian

OTHER_GOV

lead

University of Edinburgh

OTHER

NCT04866342 - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor | Biotech Hunter | Biotech Hunter